Low T-Score?

Low T-score? What it means and what to ask

A T-score compares your bone mineral density with a young-adult reference. It is useful, but it is not the whole story. Age, prior fracture, falls, medications, medical conditions, muscle, and balance all change what the number means for you 1, 2.

Topic summary

Low bone mass, often called osteopenia, generally means a T-score between -1.0 and -2.5. Osteoporosis by bone-density criteria is usually a T-score of -2.5 or lower. These cut points help organize risk, but they do not replace a full fracture-risk discussion 1, 2.

The practical question is not only, “What is my T-score?” It is, “What is my fracture risk, why is my bone density low, and what can I do about bone, muscle, mobility, nutrition, and falls?”

How to read the number

NormalAbove -1.0
Low bone mass-1.0 to -2.5
Osteoporosis range-2.5 or lower

The labels are thresholds, not destiny. A person with osteopenia and a prior low-trauma fracture may need a different conversation than a person with the same T-score and no other major risks. That is why risk tools and clinical context matter 2, 5.

Important facts to put with the score

Fracture history

A prior fragility fracture is one of the clearest signals that future fracture risk deserves attention, even before debating the exact label.

Falls and muscle

Bone density matters most when combined with real-world risk: strength, balance, vision, medications, and home hazards.

Trend over time

A single scan gives a point in time. Change over time can be meaningful only if the scans are technically comparable and interpreted carefully.

Questions to ask

  • What are the actual T-scores for my hip, femoral neck, spine, and any forearm site?
  • Does my fracture history or FRAX score change the plan?
  • Could medications, endocrine issues, kidney disease, malabsorption, low protein intake, or vitamin D deficiency be contributing?
  • What strength, balance, nutrition, or medication steps are worth discussing?

References

  1. Karaguzel G, Holick MF. Diagnosis and treatment of osteopenia. Reviews in Endocrine & Metabolic Disorders. 2010. PMID: 21234807. DOI: 10.1007/s11154-010-9154-0.
  2. Compston JE, McClung MR, Leslie WD. Osteoporosis. The Lancet. 2019. PMID: 30696576. DOI: 10.1016/S0140-6736(18)32112-3.
  3. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254-1259.
  4. Gourlay ML, Fine JP, Preisser JS, et al. Bone-density testing interval and transition to osteoporosis in older women. New England Journal of Medicine. 2012. PMID: 22256806. DOI: 10.1056/NEJMoa1107142.
  5. Morin SN, Leslie WD, Schousboe JT. Osteoporosis: A Review. JAMA. 2025. PMID: 40587168. DOI: 10.1001/jama.2025.6003.

Educational content only. This page summarizes published evidence and is not personal medical advice, diagnosis, treatment, or a substitute for care from your own clinician.